<code id='0CC90689FF'></code><style id='0CC90689FF'></style>
    • <acronym id='0CC90689FF'></acronym>
      <center id='0CC90689FF'><center id='0CC90689FF'><tfoot id='0CC90689FF'></tfoot></center><abbr id='0CC90689FF'><dir id='0CC90689FF'><tfoot id='0CC90689FF'></tfoot><noframes id='0CC90689FF'>

    • <optgroup id='0CC90689FF'><strike id='0CC90689FF'><sup id='0CC90689FF'></sup></strike><code id='0CC90689FF'></code></optgroup>
        1. <b id='0CC90689FF'><label id='0CC90689FF'><select id='0CC90689FF'><dt id='0CC90689FF'><span id='0CC90689FF'></span></dt></select></label></b><u id='0CC90689FF'></u>
          <i id='0CC90689FF'><strike id='0CC90689FF'><tt id='0CC90689FF'><pre id='0CC90689FF'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:58848
          In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp.
          Scott Olson/Getty Images

          WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

          The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends. 

          advertisement

          The negotiated prices won’t take effect until 2026. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Dario to buy mental health app maker Twill in cash and stock deal
          Dario to buy mental health app maker Twill in cash and stock deal

          AdobeDarioHealth,whichmakesappsformanagingchronicdiseases,todayannounceditwillacquiredigitalmentalhe

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Abortion clinic in Cancun will cater to Americans

          AerialviewofCancun,Mexico,whereanewabortionclinicexpectstodrawAmericantravelers.DANIELSLIM/AFPviaGet